about
Targeting Epigenetic Aberrations in Pancreatic Cancer, a New Path to Improve Patient Outcomes?Anti-fibrotic impact of Carvedilol in a CCl-4 model of liver fibrosis via serum microRNA-200a/SMAD7 enhancement to bridle TGF-β1/EMT trackUpdates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Epigenetic reprogramming in liver fibrosis and cancer.
@en
Epigenetic reprogramming in liver fibrosis and cancer.
@nl
type
label
Epigenetic reprogramming in liver fibrosis and cancer.
@en
Epigenetic reprogramming in liver fibrosis and cancer.
@nl
prefLabel
Epigenetic reprogramming in liver fibrosis and cancer.
@en
Epigenetic reprogramming in liver fibrosis and cancer.
@nl
P2093
P2860
P921
P1476
Epigenetic reprogramming in liver fibrosis and cancer.
@en
P2093
Caroline L Wilson
Derek A Mann
Lee A Borthwick
P2860
P304
P356
10.1016/J.ADDR.2017.10.011
P407
P5008
P577
2017-10-24T00:00:00Z
2017-11-01T00:00:00Z